Mentice (publ), Gothenburg, a globally recognized leader in simulation solutions for image-guided interventional therapies, announced today the appointment of Frans Venker as its new Chief Executive ...

Over the past 90 days, revenue estimates for Mentice AB have declined from $354.67 million to $340.33 million for the full year 2025, and from $423 million to $410.33 million for 2026. Similarly, ...

GOTHENBURG, Sweden--(BUSINESS WIRE)--Mentice boosts its US development presence and adds a clinical training service line with the acquisition of Medical Simulation Corporation's (MSC) Medical ...

GOTHENBURG, Sweden--(BUSINESS WIRE)--Mentice, an endovascular performance company focused on improving patient outcomes and driving operational excellence in the cath-lab, today announced the ...

Mentice (publ), Gothenburg, a globally recognized leader in simulation solutions for image-guided interventional therapies, announced today that it has secured a significant order valued at €1,062,750 ...

An extraordinary shareholders' meeting was held in Mentice AB ("the Company") on February 26, 2026. Below follows a summary of the resolutions made at the meeting. Resolution on the number of board me ...

WASHINGTON and EVANSTON, Ill., July 8 B-Line Medical, LLC and Mentice, Inc. today announced a data integration partnership facilitating integration of a broad range of Mentice products with B-Line ...

Introduction to Health Systems brings transparency, flexibility and predictability; opens new opportunities for clinicians to rapidly deploy simulation training for new and existing endovascular ...

Mentice AB, a world leader in simulation solutions for image guided interventional therapies, announced today that it has entered into an agreement to acquire all substantial assets from Paris-based ...

STOCKHOLM, Oct. 2, 2020 /PRNewswire/ -- Mentice AB (STO: MNTC) today signed a definitive agreement to acquire the New York-based medical technology company Vascular Simulations (VSI), a world-leading ...

Based on the one-year price targets offered by 2 analysts, the average target price for Mentice AB (OSTO:MNTC) is $48.30 with a high estimate of $60.00 and a low estimate of $36.60. The average target ...